XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2025
908 Devices Inc. Bioprocessing Analytics Portfolio  
Business Combination [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The components and estimated allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents

 

$

191

 

Accounts receivable

 

 

1,110

 

Inventory

 

 

6,946

 

Prepaid expenses and other current assets

 

 

651

 

Property and equipment

 

 

1,698

 

Operating lease right of use assets

 

 

2,552

 

Other assets, long-term

 

 

41

 

Customer relationships

 

 

5,040

 

Developed technology

 

 

6,910

 

Trademark and tradename

 

 

1,660

 

Goodwill

 

 

50,177

 

Accounts payable

 

 

(208

)

Accrued liabilities

 

 

(542

)

Operating lease liabilities

 

 

(2,552

)

Deferred revenue

 

 

(2,366

)

Deferred tax liability

 

 

(1,011

)

Fair value of net assets acquired

 

$

70,297

 
Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the 908 Devices PAT Portfolio acquisition and their estimated useful lives:

 

 

Useful life

 

Fair Value

 

 

 

 

 

(Amounts in thousands)

 

Customer relationships

 

8 - 9 years

 

$

5,040

 

Developed technology

 

10 - 12 years

 

 

6,910

 

Trademark and tradename

 

13 - 14 years

 

 

1,660

 

 

 

 

 

$

13,610

 
Tantti Laboratory Inc.  
Business Combination [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The components and allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents

 

$

85

 

Accounts receivable

 

 

1

 

Inventory

 

 

41

 

Prepaid expenses and other current assets

 

 

321

 

Property and equipment

 

 

731

 

Operating lease right of use asset

 

 

637

 

Other assets, long-term

 

 

81

 

Developed technology

 

 

28,910

 

Goodwill

 

 

46,943

 

Accounts payable

 

 

(18

)

Accrued liabilities

 

 

(510

)

Operating lease liabilities

 

 

(627

)

Deferred tax liability

 

 

(1,515

)

Fair value of net assets acquired

 

$

75,080

 
Metenova Holding AB  
Business Combination [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The components and allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents

 

$

5,768

 

Accounts receivable

 

 

3,730

 

Inventory

 

 

4,477

 

Prepaid expenses and other current assets

 

 

470

 

Property and equipment

 

 

433

 

Operating lease right of use asset

 

 

615

 

Customer relationships

 

 

12,659

 

Developed technology

 

 

44,377

 

Trademark and tradename

 

 

939

 

Non-competition agreements

 

 

787

 

Goodwill

 

 

115,722

 

Accounts payable

 

 

(1,432

)

Accrued liabilities

 

 

(2,934

)

Operating lease liability

 

 

(275

)

Deferred tax liability

 

 

(12,481

)

Noncurrent operating lease liability

 

 

(255

)

Fair value of net assets acquired

 

$

172,600

 
Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the Metenova Acquisition and their estimated useful lives:

 

 

Useful life

 

Fair Value

 

 

 

 

 

(Amounts in thousands)

 

Customer relationships

 

15 years

 

$

12,659

 

Developed technology

 

15 years

 

 

44,377

 

Trademark and tradename

 

15 years

 

 

939

 

Non-competition agreements

 

2 years

 

 

787

 

 

 

 

$

58,762

 

 
FlexBiosys, Inc.  
Business Combination [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The components and allocation of the purchase price consist of the following (amounts in thousands):

Cash and cash equivalents

 

$

1,090

 

Accounts receivable

 

 

683

 

Inventory

 

 

667

 

Prepaid expenses and other current assets

 

 

35

 

Property and equipment

 

 

12,034

 

Operating lease right of use asset

 

 

3,537

 

Customer relationships

 

 

2,530

 

Developed technology

 

 

9,860

 

Trademark and tradename

 

 

30

 

Non-competition agreements

 

 

220

 

Goodwill

 

 

14,321

 

Other noncurrent assets

 

 

10

 

Accounts payable

 

 

(136

)

Accrued liabilities

 

 

(314

)

Operating lease liability

 

 

(39

)

Noncurrent operating lease liability

 

 

(3,498

)

Fair value of net assets acquired

 

$

41,030

 
Schedule of Identified Intangible Assets and Estimated Useful Lives

The following table sets forth the components of the identified intangible assets associated with the FlexBiosys Acquisition and their estimated useful lives:

 

 

Useful life

 

Fair Value

 

 

 

 

 

(Amounts in thousands)

 

Customer relationships

 

12 years

 

$

2,530

 

Developed technology

 

16 years

 

 

9,860

 

Trademark and tradename

 

4 years

 

 

30

 

Non-competition agreements

 

5 years

 

 

220

 

 

 

 

$

12,640